SciELO - Scientific Electronic Library Online

 
vol.70 issue7Do we need a new look in the definition of X-linked recessive disorders?X-linked adrenoleukodystrophy in heterozygous female patients: women are not just carriers author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Arq. Neuro-Psiquiatr. vol.70 no.7 São Paulo July 2012

http://dx.doi.org/10.1590/S0004-282X2012000700002 

EDITORIAL

 

A critical view of magnetic resonance imaging in the evaluation of motor neuron diseases

 

Uma visão crítica da ressonância nuclear magnética na avaliação das doenças do neurônio motor

 

 

Cláudia da Costa Leite

MD, PhD; Neuroradiologist, Associated Professor of the Departament of Radiology at Faculdade de Medicina of Universidade de São Paulo (USP), São Paulo SP, Brazil

Correspondence

 

 

Some neurodegenerative diseases, such as Alzheimer and amyotrophic lateral sclerosis (ALS) or primary LS (PLS), do not have specific magnetic resonance imaging (MRI) findings or these findings are inconsistent, especially in their early stages. In this setting, MRI plays a role in the exclusion of other diagnosis, which could explain the clinical picture and give support for a clinical diagnosis of these entities.

New MRI techniques, also known as nonconventional or functional, have been used especially in the research field, trying to help in the early diagnosis of these neurodegenerative diseases and also as tools to monitor disease evolution and response to treatment. Sometimes, they can give additional information disclosing an extent of brain involvement, which is not evident using conventional MRI sequences, giving new insights in the understanding of their pathophysiology. The use of new imaging modalities aim at doing their earlier diagnosis1,2.

As MRI is a noninvasive and reproducible imaging method, it has been extensively applied to neurologic diseases. Nonconventional MRI techniques has been used in the assessment of multiple sclerosis and their use was expanded from the research field to drug trials and clinical practice. Magnetization transfer contrast, diffusion tensor imaging, proton spectroscopy, functional MRI, and volumetric techniques have been used to detect brain abnormalities in normal appearing white and gray matter and to evaluate function compromise or brain regional atrophy in multiple sclerosis3. The extended application of these techniques for other neurological diseases may improve diagnosis and understanding of brain involvement.

ALS/PLS is a neurodegenerative disease that affects the motor system. Clinical manifestations are related to compromise of upper and lower motor neurons. The standard diagnostic criteria for ALS/PLS, proposed by Brooks et al.4, are based on clinical findings. The most recent Awaji criteria5 associate electromyography findings and clinical manifestations for ALS/PLS diagnosis; however, imaging findings are not considered in these criteria.

Conventional MRI findings are not considered in the criteria for the diagnosis of ALS/PLS since they are not always present, and many times they are not specific (sometimes they are also identified in the normal population)1. The main role of conventional MRI nowadays is still to detect structural lesions that can exclude the diagnosis of ALS/PLS.

This issue of Arquivos de Neuro-Psiquiatria presents a very interesting review by Rocha and Maia Jr. of MRI findings in ALS/PLS that is focused on conventional and nonconventional MRI techniques, such as magnetization transfer contrast (MTC), proton spectroscopy (MRS), diffusion tensor imaging (DTI), and voxel-based morphometry (VBM)6. This article shows a critical discussion of the clinical application of these techniques in ALS/PLS in the early diagnosis, as well as in the follow-up and in the treatment control of these patients.

 

References

1. Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perpect Med 2012;2:a006213.         [ Links ]

2. Agosta F, Chio A, Cosottini M, et al. The present and future of neuroimaging in amyothropic lateral sclerosis. AJNR Am J Neuroradiol 2012;31:1769-1777.         [ Links ]

3. Fillipi M, Rocca MA, Barkhof F, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 2012;11:349-360.         [ Links ]

4. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron D. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis and other motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.         [ Links ]

5. De Carvalho M, Dengler R, Eisen A, et al. The Awaji criteria for diagnosis of ALS. Muscle Nerve 2011;43:461-463.         [ Links ]

6. Rocha AJ, Maia Júnior ACM. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routibe. Arq Neuropsiquiatr 2012;70:532-539.         [ Links ]

 

 

Correspondence:
Cláudia da Costa Leite

Instituto de Radiologia, Setor de Ressonância Magnética
Rua Doutor Enéas de Carvalho Aguiar 255 / portaria 5 / 3º andar
05403-001 São Paulo SP - Brasil
E-mail: claudia.leite@hc.fm.usp.br

Received 09 May 2012
Accepted 16 May 2012

 

 

Conflict of interest
There is no conflict of interest to declare.